Cancer of the uterus is the sixth most common cancer type in New Zealand. Uterus cancer and endometrial cancer are types of gynaecological cancer.
Uterus and Gynaecological Cancer Research Areas Involving NZ Researchers:
Uterus and Gynaecological Cancer and Behavioural Research
Uterus and Gynaecological Cancer Biology
Professor John Evans, Dr Noelyn Hung, Dr Tania Slatter,
Endometrial cancer: molecular biology, Professor Parry Guilford, Granulosa cell tumours: Dr Kenny Chitcholtan, Professor Andrew Shelling, Professor Margreet Vissers, Associate Professor Gabi Dachs, Dr Nick Fleming, Professor Helen Nicholson,
Ovarian cancer: Professor Andrew Shelling, Dr Qi Chen, Dr Anita Muthukaruppan, Professor Bridget Robinson, Dr Kenny Chitcholtan, Dr Logan Walker, Dr Stephanie Bozonet, Dr Heather Cunliffe, Adjunct Professor Mac Gardner, Dr Karen Reader, Oncolytic adenoviral mutants for treatment of: Dr Sarah Baird
Uterus and Gynaecological Cancer Screening (and Epidemiology)
Ovarian cancer: Professor Ann Richardson,
Uterus and Gynaecological Cancer Treatment, Including Clinical Trials
Associate Professor Nuala Helsby, Dr Dhiraj Kumar, Mrs Dianne Harker,
Standards Of Service Provision For Gynaecological Cancer Patients In New Zealand – Provisional
This provisional gynaecological cancer tumour standard describes the level of service that a person with gynaecological cancer in New Zealand should have access to. All of the recently developed provisional tumour standards include a number of standard statements that are generic across most cancers; they apply to all people with cancer and to all cancer types.
International Research on Uterus and Gynaecological Cancer
OVERVIEW
The uterus is a hollow, muscular organ where a fetus grows. Uterine cancer can start in different parts of the uterus. Most uterine cancers start in the endometrium (the inner lining of the uterus). This is called endometrial cancer. Most endometrial cancers are adenocarcinomas (cancers that begin in cells that make mucus and other fluids).
Uterine sarcoma is an uncommon form of uterine cancer that forms in the muscle and tissue that support the uterus.
Obesity, certain inherited conditions, and taking estrogen alone (without progesterone) can increase the risk of endometrial cancer. Radiation therapy to the pelvis can increase the risk of uterine sarcoma. Taking tamoxifen for breast cancer can increase the risk of both endometrial cancer and uterine sarcoma.
The most common sign of endometrial cancer is unusual vaginal bleeding. Endometrial cancer can usually be cured. Uterine sarcoma is harder to cure.
Endometrial Cancer Treatment –Patient Version
Uterine Sarcoma Treatment – Patient Version
Endometrial Cancer Prevention – Patient Version
Endometrial Cancer Screening – Patient Version
Endometrial Cancer Treatment – Health Professional Version
Uterine Sarcoma Treatment – Health Professional Version
Endometrial Cancer Prevention – Health Professional Version